Kane Biotech Inc. Appoints John Coleman to the Board of Directors
Formerly, Dr. Coleman served as the Department Head for the Project Search and Evaluation Division of the Centre for Drug Research and Development (CDRD, now adMare) from 2007 to 2015. His earlier experiences include diverse roles at Inflazyme Pharmaceuticals Ltd., a Vancouver-based biotechnology company specializing in treatments for respiratory and inflammatory diseases and leading the natural products group at Ocean Nutrition Canada in Halifax, Nova Scotia. John Coleman holds a BSc. (Honours) from Bishop?s University (1992) and a PhD from the University of British Columbia (1997). He is currently the President and CEO of Avivo Biomedical Inc.